Article Information
- Received October 8, 2002
- Revision received December 11, 2002
- Accepted December 12, 2002
- First published March 1, 2003.
- Version of record published March 1, 2003.
Author Information
Author contributions
Disclosures
- Received October 8, 2002.
- Revision received December 11, 2002.
- Accepted December 12, 2002.
This work was supported by grants from Aventis Pharmaceuticals to D.L.P. and S.A.L.B., the Natural Sciences and Engineering Research Council of Canada (NSERC) to S.A.L.B., and a Premier's Research Excellence Award to S.A.L.B. S.A.L.B. is an Ontario Mental Health Foundation Intermediate Investigator. L.M.D. is supported by an NSERC studentship. S.D. is supported by an NSERC undergraduate studentship. We thank Dr. Klaus Willecke for providing connexin32 knock-out breeding pairs and Jim Bennett for excellent technical assistance.
Correspondence should be addressed to Dr. Steffany Bennett, Neural Regeneration Laboratory, Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada K1H 8M5. E-mail: sbennet{at}uottawa.ca.
C. Sellitto's present address: Department of Physiology and Biophysics, State University of New York at Stony Brook, Stony Brook, NY 11794-8661.
Online Impact